CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...